Zobrazeno 1 - 10
of 948
pro vyhledávání: '"salivary gland carcinoma"'
Autor:
Takashi Matsuki, Daisuke Kawakita, Hideaki Takahashi, Takuro Okada, Akihiro Sakai, Yushi Ueki, Hiroshi Tsuge, Kenji Hanyu, Kaho Momiyama, Ryusuke Shodo, Mayu Yamauchi, Yukiko Asako, Hideaki Hirai, Toshitaka Nagao, Yuichiro Tada
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Although immune checkpoint inhibitors (ICIs) are effective in some patients with salivary gland carcinoma (SGC), biomarkers which predict the efficacy and prognosis of SGC patients treated with pembrolizumab have not been identified. We cond
Externí odkaz:
https://doaj.org/article/b5b7acb4c83f4a13bea2ec729ee7a8c0
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundLow-grade salivary gland carcinoma is regularly treated with surgical therapy of the salivary gland without elective neck dissection in T1/2 carcinomas, either alone or with adjuvant radiation therapy. However, occult metastasis and locoreg
Externí odkaz:
https://doaj.org/article/5fd68bac0eea413a9a6180c6504a14dc
Publikováno v:
Acta Oto-Laryngologica Case Reports, Vol 8, Iss 1, Pp 38-43 (2023)
AbstractWe present a patient diagnosed with a parotid tumor whose histopathology was MASC. A 58-year-old female presented with a 5-month history of an enlarging right parotid mass. Ultrasonography showed a 48 × 30 mm heterogeneous solid lesion with
Externí odkaz:
https://doaj.org/article/af3a5eb103c645ab997b92d9c9470703
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/f1859e8af01a499fa1a052b2529c09ae
Publikováno v:
Acta Oto-Laryngologica Case Reports, Vol 8, Iss 1, Pp 44-46 (2023)
AbstractMucoepidermoid carcinoma (MEC) is one of the most common histological malignant salivary gland tumors, it is most frequently diagnosed in the parotid gland. MEC is also diagnosed in the intra oral minor salivary glands. Only a few cases of to
Externí odkaz:
https://doaj.org/article/7f11cc88ac3247efac2f76e481c4c54c
Autor:
Dominik T. Schneider, Daniel Orbach, Calogero Virgone, Yves Reguerre, Jan Godzinski, Ewa Bien, Gianni Bisogno, Jelena Roganovic, Nuno Reis Farinha, Tal Ben-Ami, Teresa Stachowicz-Stencel, Anna Synakiewicz, Bernadette Brennan, Stefano Chiaravalli, Benedikt Bernbeck, Coralie Mallebranche, Vincent Couloigner, Michael Abele, Ines B. Brecht, Andrea Ferrari
Publikováno v:
EJC Paediatric Oncology, Vol 2, Iss , Pp 100129- (2023)
Background: Salivary gland carcinomas (SGCs) are exceedingly rare in children, with a reported annual incidence of 0.8–1.4/1000,000 under 20 years of age. Evidence regarding optimal treatment of pediatric SGCs is limited, and for a long time, no gu
Externí odkaz:
https://doaj.org/article/ddc7cbd36d484199988b1d7cff27f17c
Publikováno v:
Clinical Case Reports, Vol 11, Iss 10, Pp n/a-n/a (2023)
Key Clinical Message HRAS mutations are frequent genetic alterations in epithelial‐myoepithelial carcinoma, and they may be useful as ancillary molecular tests and predictive molecular tests for targeted therapy with tipifarnib.
Externí odkaz:
https://doaj.org/article/7f9bc0e80562459088c9fe653ad3e4e3
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 2772-2781 (2023)
Abstract Background Postoperative radiotherapy (PORT) is beneficial in the improvement of local‐regional control and overall survival (OS) for major salivary gland carcinomas (SGCs), and distant metastasis remained the main failure pattern. This st
Externí odkaz:
https://doaj.org/article/41a015d259df4382be42ac79c6dfe8e4
Autor:
Ryosuke Sato, Takumi Kumai, Yoshiya Ishida, Ryota Yuasa, Akinobu Kubota, Risa Wakisaka, Hiroki Komatsuda, Hidekiyo Yamaki, Tetsuji Wada, Yasuaki Harabuchi
Publikováno v:
Laryngoscope Investigative Otolaryngology, Vol 7, Iss 6, Pp 1808-1813 (2022)
Abstract Objective Immune checkpoint inhibitors (ICIs) have been considered as novel therapeutic approaches for various cancers. ICIs were reportedly efficacious against rare cancers, including salivary gland carcinoma (SGC). We aimed to analyze the
Externí odkaz:
https://doaj.org/article/ca0a211bf99d4de2a49a0285761b8603
Autor:
Etsuko Moriyama, Sachiko Nagasu, Toshimitsu Tanaka, Yasutaka Shimotsuura, Takeharu Ono, Hirohito Umeno, Jun Akiba, Akihiko Kawahara, Fumihiko Fujita, Takumi Kawaguchi, Keisuke Miwa
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionExpression of the NTRK gene is rare in solid tumors but is highly prevalent in salivary gland secretory carcinomas. Here, we report a case of a complete response to entrectinib in a patient with NTRK fusion gene-positive parotid carcinoma
Externí odkaz:
https://doaj.org/article/45cb8b3a60314a6b90e4a2ad32d1cbf3